JP2003511403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003511403A5 JP2003511403A5 JP2001529412A JP2001529412A JP2003511403A5 JP 2003511403 A5 JP2003511403 A5 JP 2003511403A5 JP 2001529412 A JP2001529412 A JP 2001529412A JP 2001529412 A JP2001529412 A JP 2001529412A JP 2003511403 A5 JP2003511403 A5 JP 2003511403A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage unit
- mirtazapine
- unit according
- mouth
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 description 5
- 229960001785 mirtazapine Drugs 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 3
- 239000002245 particle Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99203338 | 1999-10-13 | ||
| EP99203338.1 | 1999-10-13 | ||
| PCT/EP2000/009863 WO2001026621A2 (en) | 1999-10-13 | 2000-10-09 | Orally distintegrating composition comprising mirtazapine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003511403A JP2003511403A (ja) | 2003-03-25 |
| JP2003511403A5 true JP2003511403A5 (enExample) | 2007-11-22 |
| JP5561885B2 JP5561885B2 (ja) | 2014-07-30 |
Family
ID=8240737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001529412A Expired - Lifetime JP5561885B2 (ja) | 1999-10-13 | 2000-10-09 | ミルタザピンの新しい配合物 |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1223914B1 (enExample) |
| JP (1) | JP5561885B2 (enExample) |
| KR (1) | KR100708560B1 (enExample) |
| CN (1) | CN1173701C (enExample) |
| AR (1) | AR026010A1 (enExample) |
| AT (1) | ATE274899T1 (enExample) |
| AU (1) | AU780379B2 (enExample) |
| BR (1) | BR0014593A (enExample) |
| CA (1) | CA2386547C (enExample) |
| CO (1) | CO5251412A1 (enExample) |
| CZ (1) | CZ20021315A3 (enExample) |
| DE (2) | DE1223914T1 (enExample) |
| ES (1) | ES2194618T3 (enExample) |
| HK (1) | HK1046641B (enExample) |
| HU (1) | HUP0203148A3 (enExample) |
| IL (2) | IL148777A0 (enExample) |
| MX (1) | MXPA02003519A (enExample) |
| NO (1) | NO20021730L (enExample) |
| NZ (1) | NZ518165A (enExample) |
| PE (1) | PE20010699A1 (enExample) |
| PL (1) | PL200858B1 (enExample) |
| PT (1) | PT1223914E (enExample) |
| RU (1) | RU2261098C2 (enExample) |
| SK (1) | SK6452002A3 (enExample) |
| TR (1) | TR200200978T2 (enExample) |
| TW (1) | TWI256309B (enExample) |
| WO (1) | WO2001026621A2 (enExample) |
| ZA (1) | ZA200202293B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL372290A1 (en) * | 2002-02-07 | 2005-07-11 | Pharmacia Corporation | Pharmaceutical dosage form for mucosal delivery |
| WO2005051349A2 (en) * | 2003-11-25 | 2005-06-09 | Aurobindo Pharma Ltd. | Pharmaceutical compositions of mirtazapine |
| DE102004034043A1 (de) * | 2004-07-13 | 2006-02-09 | Krka Tovarna Zdravil, D.D. | Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält |
| CA2643802A1 (en) * | 2006-02-27 | 2007-09-07 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
| CN101129341B (zh) * | 2006-08-22 | 2011-06-01 | 上海医药工业研究院 | 口内崩解组合物及其制备方法 |
| EP2377522B1 (en) | 2010-04-15 | 2013-01-16 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablet formulations of mirtazapine and process for preparing the same |
| CN102993208B (zh) * | 2011-11-22 | 2017-01-18 | 北京哈三联科技股份有限公司 | 去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用 |
| CA2852042C (en) * | 2012-03-02 | 2018-05-01 | Rhodes Pharmaceuticals L.P. | Tamper resistant immediate release formulations |
| CN104095824B (zh) * | 2013-04-09 | 2016-08-31 | 上海信谊万象药业股份有限公司 | 一种米氮平缓释片及其制备方法 |
| PL3261645T3 (pl) | 2015-02-27 | 2021-12-06 | Dechra Limited | Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów |
| JP6601844B2 (ja) * | 2016-12-05 | 2019-11-06 | 共和薬品工業株式会社 | 光安定性に優れたミルタザピン含有医薬製剤 |
| CN111714463B (zh) * | 2020-08-14 | 2022-06-17 | 华农（肇庆）生物产业技术研究院有限公司 | 米氮平口服剂及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
| AU646232B2 (en) * | 1989-10-02 | 1994-02-17 | Cima Labs, Inc. | Effervescent dosage form and method of administering same |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| IE63986B1 (en) * | 1989-12-30 | 1995-06-28 | Akzo Nv | Pharmaceutical preparation for oral administration in fluid form |
| JPH0436252A (ja) * | 1990-05-30 | 1992-02-06 | Nippon Alkyl Alum Kk | 光学活性アルキニルアルコールの製造方法 |
| JP3168695B2 (ja) * | 1991-06-14 | 2001-05-21 | 三菱化学株式会社 | ショ糖脂肪酸エステルの置換度の低下方法 |
| US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
| JPH05163137A (ja) * | 1991-12-12 | 1993-06-29 | Shin Etsu Chem Co Ltd | 有核顆粒 |
| ATE148443T1 (de) * | 1992-10-07 | 1997-02-15 | Akzo Nobel Nv | Verfahren zur trennung von enantiomeren aus einer racemischen mischung |
| CA2128820A1 (en) * | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
| JPH0737473A (ja) * | 1993-07-27 | 1995-02-07 | Murata Mfg Co Ltd | 圧力スイッチ |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| JPH10139659A (ja) * | 1996-09-10 | 1998-05-26 | Freunt Ind Co Ltd | 球形粒子群、その製造方法及びそれを用いた球形粒子製剤 |
| JP3870470B2 (ja) * | 1997-02-07 | 2007-01-17 | 大正製薬株式会社 | マルチプルユニットタイプ徐放性錠剤 |
-
2000
- 2000-09-19 TW TW089119264A patent/TWI256309B/zh not_active IP Right Cessation
- 2000-10-09 JP JP2001529412A patent/JP5561885B2/ja not_active Expired - Lifetime
- 2000-10-09 WO PCT/EP2000/009863 patent/WO2001026621A2/en not_active Ceased
- 2000-10-09 AU AU10232/01A patent/AU780379B2/en not_active Expired
- 2000-10-09 BR BR0014593-9A patent/BR0014593A/pt not_active Application Discontinuation
- 2000-10-09 AT AT00971346T patent/ATE274899T1/de active
- 2000-10-09 HU HU0203148A patent/HUP0203148A3/hu unknown
- 2000-10-09 DE DE1223914T patent/DE1223914T1/de active Pending
- 2000-10-09 IL IL14877700A patent/IL148777A0/xx unknown
- 2000-10-09 RU RU2002112238/15A patent/RU2261098C2/ru active
- 2000-10-09 PT PT00971346T patent/PT1223914E/pt unknown
- 2000-10-09 KR KR1020027004668A patent/KR100708560B1/ko not_active Expired - Lifetime
- 2000-10-09 HK HK02108207.0A patent/HK1046641B/en not_active IP Right Cessation
- 2000-10-09 ES ES00971346T patent/ES2194618T3/es not_active Expired - Lifetime
- 2000-10-09 EP EP00971346A patent/EP1223914B1/en not_active Revoked
- 2000-10-09 SK SK645-2002A patent/SK6452002A3/sk not_active Application Discontinuation
- 2000-10-09 NZ NZ518165A patent/NZ518165A/en not_active IP Right Cessation
- 2000-10-09 MX MXPA02003519A patent/MXPA02003519A/es unknown
- 2000-10-09 CA CA2386547A patent/CA2386547C/en not_active Expired - Fee Related
- 2000-10-09 DE DE60013466T patent/DE60013466T2/de not_active Expired - Lifetime
- 2000-10-09 PL PL354584A patent/PL200858B1/pl unknown
- 2000-10-09 TR TR2002/00978T patent/TR200200978T2/xx unknown
- 2000-10-09 CZ CZ20021315A patent/CZ20021315A3/cs unknown
- 2000-10-09 CN CNB008142041A patent/CN1173701C/zh not_active Expired - Lifetime
- 2000-10-11 AR ARP000105347A patent/AR026010A1/es not_active Application Discontinuation
- 2000-10-12 CO CO00077918A patent/CO5251412A1/es active IP Right Grant
- 2000-10-13 PE PE2000001100A patent/PE20010699A1/es not_active IP Right Cessation
-
2002
- 2002-03-20 IL IL148777A patent/IL148777A/en not_active IP Right Cessation
- 2002-03-20 ZA ZA200202293A patent/ZA200202293B/en unknown
- 2002-04-12 NO NO20021730A patent/NO20021730L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11452689B2 (en) | Taste-masked pharmaceutical compositions | |
| Reddy et al. | A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods | |
| JPH11509223A5 (enExample) | ||
| EP1809251B1 (en) | Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane | |
| ES2337547T3 (es) | Composiciones de liberacion controlada que contienen nimesulida. | |
| JP2006514058A (ja) | 薬物の経口投与用の急速溶解フィルム | |
| US20090110717A1 (en) | Transmucosal composition | |
| JP2005536568A5 (enExample) | ||
| NO325073B1 (no) | Preparat for anvendelse i munnhulen med en film eller sjikt som viser oyeblikkelig fuktbarhet. | |
| JP2003511403A5 (enExample) | ||
| JP2013079265A (ja) | 薬物置換療法のためのブプレノルフィンウェハー | |
| CA2371940A1 (en) | Pregelatinized starch in a controlled release formulation | |
| CN101534792A (zh) | 包含氧可酮的粒剂和口腔崩解片剂 | |
| CA2497176A1 (en) | Taste masked dosage forms and processes for their preparation | |
| JP2003530423A5 (enExample) | ||
| AU2001231018A1 (en) | Multi-spike release formulation for drug delivery | |
| WO2006047493A3 (en) | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers | |
| CN1130061A (zh) | 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣 | |
| JPH09500910A (ja) | パラセタモール及びドンペリドンのフィルムコーティング錠 | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| Gijare et al. | Orodispersible films: a systematic patent review | |
| CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
| CA2386547A1 (en) | Orally disintegrating composition comprising mirtazapine | |
| CA2417887A1 (en) | Particulate composition of eletriptan | |
| JP2001511450A5 (enExample) |